NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
National Institutes of Health
Posted Oct 23, 2026
Description
This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.
AI Summary
This NIH funding opportunity supports investigators in developing new devices for preventing, monitoring, diagnosing, or treating disorders, with a focus on neurological conditions and addiction under the BRAIN and HEAL Initiatives. Funded work covers taking promising early-stage technologies through optimization and the preparatory studies needed to reach first-in-human clinical testing, but the opportunity itself does not fund the clinical trials. Applicants should be investigators working on device translation who have already shown proof of concept.
Funding Details
Key Dates
Quick Facts
- CFDA Number
- 93.853
- Funder Type
- Federal Agency
- Grant Level
- FEDERAL
- Last Verified
- Oct 23, 2026
Categories
Geographic Scope
national
GL-78455D78455d24-2231-4e99-b245-277c03d41604
Intelligence
Ready to apply?
Visit the funder's website to start your application.